- Health Topics
- The Science
- Grants and Training
- News and Events
- About NHLBI
All News
|
Research Feature
A cell-based look at how the body responds to immune threats may one day help researchers find better treatments for this major U.S. killer For more than a decade, researchers have known that a core component of human immune function – called complement – can influence how the body responds to immune threats. Now researchers from the NIH and around...
Showing 10 out of 2065 results
|
NHLBI in the Press
After reviewing decades of data from 90,000 health professionals, researchers found adults who consumed more than a half-teaspoon of daily olive oil were less likely to die early. Similar associations followed simulations of swapping olive oil for margarine, butter, and mayonnaise.
|
Research Feature
A cell-based look at how the body responds to immune threats may one day help researchers find better treatments for this major U.S. killer For more than a decade, researchers have known that a core component of human immune function – called complement – can influence how the body responds to immune threats. Now researchers from the NIH and around...
Credit: American Heart Association
|
NHLBI in the Press
Researchers tracked blood pressure levels of 464,585 adults over a three-year period and found systolic blood pressure levels increased by an average of 1.1- 2.5 mm Hg throughout the pandemic.
|
NHLBI in the Press
Researchers are reporting for the first time that cardiovascular disease affects the blood vessels in the bone marrow and leads to increased production of white blood cells that drive inflammation.
|
Media Availability
NIH-wide initiative details efforts to advance sleep and circadian biology research WHAT: The National Institutes of Health’s Sleep Research Plan outlines five goals and nine critical research opportunities to advance sleep and circadian biology research. Key features of the plan focus on studying sleep and circadian mechanisms that underlie health...
|
NHLBI in the Press
An experimental gene therapy approach for treating sickle cell disease shows promise for eliminating painful crises that are associated with the condition, according to interim findings from a clinical trial.
|
Research Feature
NIH research continues to evaluate how blood thinners and anti-inflammatory medications may strengthen recovery at different points in the life of the virus W. Keith Hoots, M.D., director of the Division of Blood Disorders and Resources (DBDR) at the National Heart, Lung, and Blood Institute (NHLBI), shares insight into how treatments that break up...
|
Research Feature
Severe blood clotting in patients has sent researchers in search of answers to optimize treatment and recovery As the virus that causes COVID-19 invades cells and replicates its code for infection, the body’s immune response fights back. However, for some people this can lead to extreme blood clotting – which can increase the risk for heart attack...
|
News Release
Researchers have linked a rare genetic mutation found mostly in Black Americans and other people of African descent to an earlier onset of heart failure and a higher risk of hospitalization. The findings suggest that earlier screening for the mutation could lead to faster treatment and improved outcomes for heart failure in this vulnerable group...
|
NHLBI in the Press
Researchers have linked a rare genetic mutation found mostly in Black Americans and other people of African descent to an earlier onset of heart failure and a higher risk of hospitalization.